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Summary: Iminodipeptides containing C-terminal proline or hydroxyproline were determined in sera from patients
with prolidase deficiency, in their mother's serum, and in the sera of unfelated controls, using liquid chromatogra-
phy-mass Spectrometry with an atmospheric pressure ionization interface System. The Separation was carried out on
a reversed phase column using l g/l aqueous trifluoroacetic acid-methanol (75 + 25, by vol.). The quasi-molecular
ions ([M -l· H])"1" of various Iminodipeptides containing C-terminal proline and hydroxyproline were observed in
the sera of patients with prolidase deficiency, using selected ipn monitoring. The quasi-molecular ions ([M + H])+
of iminodipeptides containing C-terminal proline were not observed in the sera of normal subjects or the patients'
mother, but the latter did contain various iminodipeptides with C-terminal hydroxyproline. This method proved
usefiil for the determination of iminodipeptides in the sera of patients with prolidase deficiency.
Introduction
Prolidase (EC 3.4.13.9) deficiency is a rare autosomal
recessive disease characterized by chronic ulcerative
dermatitis and mental retardation (l, 2). These patients
also excrete large amounts of iminodipeptides in the ur-
ine(l-3).
The iminodipeptides excreted by patients have been
demonstrated by amirio acid analysis (1—3) and by iso-
tachophoresis (4). However, these methods are unsuit-
able for the exact identification of urmary iminodipep-
tides.
The analyses of mixtures of non-volatile compounds us-
ing liquid chromatography combined with atmospheric
pressure ionization mass Spectrometry (LC-APCI-MS)
has recently produced promising results in different fi-
elds (5).
We previously reported the identification of a series of
synthetic iminodipeptides containing a C-terminal pro-
line or hydroxyproline, äs well äs various endogenous
iminodipeptides, in the urine of patients with iminodi-
peptiduria, using LC-APCI-MS (6).
The iminodipeptides in the sera of patients with prolid-
ase deficiency could not be detected by scan mode, be-
cause the concentration of iminodipeptides in sera is
much lower than that in urine.
The present paper describes the identification of various
iminodipeptides containing C-terminal proline or
hydroxyproline in the sera of patients with prolidase de-
ficiency, in the serum of their mother, and in normal
subjects, using selected ion monitoring.
Experimental
Materials
Gly-Pro, Ala-Pro, Val-Pro, Leu-Pro, Ser-Pro, Thr-Pro, Met-Pro,
Pro-Pro, Pro-Hyp and Gly-Hyp were purchased from Sigma. All
other chemicals were of analytical grade.
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 32,1994 / No. 3
114 Sugahara et al.: Iminodipeptides in serum of prolidase deficiency patients
Serum samples
The samples of normal human scrum were obtained from labora-
1017 personnel. The samples from patients with prolidase deficiency
and their mother wcre obtained from two girls (sisters) and their
mother, s reported previously (3,4).
I n s t r u m e n t a t i o n (mass spectrometry)
The apparatus used was an Hitachi L-6200 HPLC Instrument,
equipped with a 5-μπι Inertsil ODS-2 packed column (150 mm
X 4.6 mm 1. D.) from Gasukuro Kogyo (Tokyo, Japan), connected
to a Hitachi M80B mass spectrometer-computer System, through
the APCI interface (7, 8). The nebulizer and vaporizer temperatures
were 320 and 380 °C, respectively. Analyses of Standard and serum
in iminodipeptides were carried out with a mobile phase of l g/l
trifluoroacetic acid-methanol (75 + 25, by vol.) at a flow-rate of
0.9 ml/min.
Preparation of samples
Six ml of 20 g/l sulphosalicylic acid were added to 2 ml of serum,
stirred and centrifuged at 3000 min"1 for 10 min. The supernatant
was transferred to a column containing 10 ml of Diaion SK-1 (H+
form, 100 mesh, Mitsubishi Kasei, Tokyo, Japan) and washed with
50 ml of water. The iminodipeptides were then eluted with 2 mol/1
ammonia. The eluate was evaporated to dryness in vacuo. The resi-
due was dissolved in 0.2 ml of water, then subjected to LC-
APCI-MS.
Assay of prolidase activity
Erythrocyte lysates were prepared from the heparinized blood of
patients and normal volunteers according to Umemura's method
(9). A mixture containing 10 μΐ of diluted erythrocyte lysate, 10 μΐ
of 10 mmol/1 MnCl2 and 80 μΐ of 50 mmol/1 Tris-HCl (pH 7.8)
was preincubated for 10 min at 37 °C, then incubated with 100 μΐ
of 10 mmol/1 Substrate (X-Pro) in l mmol/1 MnCl2 for 30 min at
37 °C. The reaction was terminated by the addition of 200 μΐ of
100 g/l trichloroacetic acid solution. After 10 min at 90 °C with
Chinard's reagent (10), which consisted of ninhydrin, phosphoric
acid and acetic acid, liberated proline was estimated by spectropho-
tometry (wavelength 515 nm). The activity towards X-Hyp was
assayed according to the method reported previously (11).
Results and Discussion
The various iminodipeptides in the urine of patients with
prolidase deficiency were easily observed by scan mode
using LC-APCI-MS, but since the concentration of im-
inodipeptides is much lower in serum than in urine, the
scan mode was of no use for the analysis of serum
iminodipeptides.
Therefore, iminodipeptides were analysed in serum us-
ing selected ion monitoring which is more sensitive than
the scan mode.
Selected ion monitoring chromatograms of quasi mol-
ecular ions [M + H]+ of the Standard iminodipeptides,
Gly-Pro, Ala-Pro, Val-Pro, Leu-Pro, Ser-Pro, Pro-Pro,
Gly-Hyp and Pro-Hyp, obtained using the LC-APCI-MS
System are shown in figure 1. These iminodipeptides
were easily observed by scanning their quasi-molecular
ions [M + H]+.
Selected ion monitoring chromatograms of quasi-mol-
ecular ions [M + H] of various iminodipeptides in sera
frorn patients (sisters) with prolidase deficiency and
their mother are shown in figure 2. The quasi-molecular
ions [M + H]+ of Gly-Pro, Ala-Pro, Val-Pro, Leu-Pro,
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Fig. l Selected ion monitoring chromatogram of autheritic imi-
nodipeptides, Gly-Pro ([M + H] 173), Ala-Pro (187), VaWPro
(215), Pro-Hyp (229-a), Leu-Pro (229-b), Ser-Pro (203), Pro-Pro
(213) and Gly-Hyp (189).
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Fig. 2 Selected ion monitoring chromatograms of iminodipep^
tides in the serum samples from a patient with prolidase deficiency
(A) and her mother (B).
Gly-Pro ([M + H] 173), Ala-Pro (187), VaWPro (215), Pro-Hyp
(229-a), Ile-Pro (229-b), Leu-Pro (229rc), Ser-Pro (203), Pro-Pro
(213), Gly-Hyp (189).
 ;;
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Ile-Pro, Ser-Pro, Pro-Pro, Gly-Hyp and Pro-Hyp were
observed in the serum of a patient with prolidase de-
ficiency (fig. 2a). The quasi-molecular ions [M + H]4"
of iminodipeptides containing C-terminal proline were
not observed in the serum of the patient's mother (fig.
2b) or normal subjects, but the quasi-molecular ions
[M + H]+ of iminodipeptides containing C-terminal
hydroxyproline, Gly-Hyp and Pro-Hyp were clearly ob-
served.
In the LOAPCI-MS System, quasi-molecular ions
[M + H]+, [M + H]-H2O, and proline residue + 2H
(m/z 116) were commonly observed in the mass spectra
of iminodipeptides äs reported previously (6,7).
Selected ion monitoring chromatograms of the simul-
taneous scanning of the [M + H]+ ion - H2O and pro-
line residue + 2H (m/z 116) are shown in figures 3a, b,
c for Gly-Pro, for Pro-Pro and for a mixture of these
two dipeptides.
The peaks of the [M + H]"1" ion, [M -f - H2O, and
proline residue + 2H of Gly-Pro or Pro-Pro have the
same retention time (figs. 3a and b).
On the other band, in a chromatogram of a mixture of
these two compounds, the [M + H]+ ion and [M + H]+
— H2O ion of Gly-Pro or Pro-Pro have the same reten-
tion time, but the peak of the proline residue -l· 2H over-
laps and is unclear (fig. 3c).
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Fig. 3 Selected ion monitoring chromatograras of the [M + H]
ion (213), [M + H] - H2O ion (195) and proline residue + 2H
ion (116) of Pro-Pro (a); the [M -h H] ion (173), [M + H] - H2O
ion (155) and proline residue + 2H ion (116) of Gly-Pro (b); the
same ions in a mixture of these two dipeptides (c),
Therefore, the identification of iminodipeptides was
based on the simultaneous scanning of [M + H]+ ion
and [M -f H]+ - H2O, and their retention time.
Selected ion monitoring chromatograms from the simul-
taneous scanning of the [M + H]+ ion and [M + H]+
- H2O ion (Gly-Pro and Pro-Pro) in the serum of a
patient with prolidase deficiency are shown in figure 4.
In each chromatogram, the peaks of the [M + H]+ and
[M + H]+ - H2O ions for Gly-Pro and Pro-Pro have
the same retention times äs those of Standard Gly-Pro
and Pro-Pro. These results indicate that the various
iminodipeptides in the serum of a patient with iminodi-
peptiduria can be identified by selected ion monitoring.
The Standard curve for different concentrations bf Gly-
Pro is shown in figure 5. The slope of the curve was
linear over the concentration ranges from 100 nmol to
500 nmol.
The recovery of Standard iminodipeptides after ion ex-
change resin treatment was approximately 94%, ranging
from 80 to 103%, which indicates that the method is
reliable for the measurement of iminodipeptides in bio-
logical samples.
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Fig. 4 Selected ion monitoring chromatogram of the [M + H] ion
(173) and [M H-H] - H2O ion (155) from Gly-Pro, and the
[M + H] ion (213) and [M + H] - H2O (195) of Pro-Pro in the
serum from a patient with prolidase deficiency.
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Fig. 5 Calibration curve for Gly-Pro, showing concentrations
plotted against peak areas.
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Several iminodipeptides (Gly-Pro; m/z 173, Ser-Pro;
m/z 203, Pro-Pro; m/z 213, Gly-Hyp(a), Ile-Pro(b), Leu-
Pro(c); m/z 229) were found in the serum of a patient
vvith prolidase deficiency, using selected ion monitoring
(fig. 6). The resulting chromatogram showed clear peaks
of iminodipeptides with no interference from other
peaks,
Quantification of various iminodipeptides in sera from
patients with prolidase deficiency, their mother and nor-
mal subjects, based on peak areas, is shown in table 1.
The iminodipeptides containing C-terminal proline or
hydroxyproline (Pro-Hyp) were increased in serum from
patients with prolidase deficiency.
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Fig. 6 Selected ion monitoring norraalized chromatograms of
Gly-Pro (173), Ser-Pro (203), Pro-Pro (213), Pro-Hyp (229-a), Ile-
Pro (229-b) and Leu-Pro (229-c) in the serum frörh a patient with
prolidase deficiency.
Tab. l Concentrations of various iminodipeptides in the sera of
patients with prolidase deficiency, their mother and a control (mean
± SD (n = 3), mg/1).
Gly-Pro
Ala-Pro
Val-Pro
Leu-Pro
Ile-Pro
Ser-Pro
Pro-Pro
Gly-Hyp
Pro-Hyp
Met-Pro
Patient A
2.77 ± 0.09
1.56 ±0.22
2.02 ± 1.38
2.12 ±0.53
1.98 ±0.55
2.09 ± 0.28
5. 10 ±0.79
+
1.27 ±0.32
ND
Patient B
2.95 ± 0.22
1.58 ±0.17
1.57 ± 0.71
3.49 ± 0.44
2.43 ± 0.14
1.76 ±0.36
5.27 ± 0.32
+
1.35 ±0.73
ND
Mother
ND
ND
ND
ND
ND
ND
ND
+
+
ND
Control
ND
ND
ND
ND
ND
ND
ND
+
+
ND
ND: not detectable
The X-Pro dipeptides could not be detected in sera from
the patients' mother and from normal subjects, but the
peaks corresponding to Gly-Hyp and Pro-Hyp were de-
tected on selected ion monitoring chromatograms
(fig. 7).
Serum Pro-Hyp in siblings with' prolidase deficiency
was much higher than in either their mother or normal
subjects.
The amounts of Gly-Hyp in serum from patients with
prolidase deficiency, and of Gly-Hyp and Pro-Hyp in
sera from their mother and normal subjects could not be
exactly determined due to interference from other peaks.
Prolidase activities against X-Pro and X-Hyp were de-
termined in erythrocytes from patients, their mother and
normal subjects, using the method described previously
(11). The prolidase activities of patients towards Gly-
Pro and Pro-Pro were very low compared with contröls,
and the mother had approximately half äs much activity
äs normal subjects, which agreed with a previous report
(12). The prolidase activities of patients and normal sufc
jects towards Gly-Hyp and Pro-Hyp were much lower
than those towards Gly-Pro and Pro-Pro.
In patients with prolidase deficiency there was a com-
plete deficiency of prolidase I, which shows the highest
activity towards Gly-Pro.
Prolidase II, which is active mainly against MeUPro,
shows the same activity in patients äs in normal sub-
jects.
Complete digestion of Met-Pro by prolidase II seems to
be the reasori why Met-Pro cannot be detected at all in
serum samples from patients with prolidase deficiency
(tab. 1).
The present investigations showed the presence of serum
Gly-Hyp and Pro-Hyp not only in the patients, but also
in their mother and normal subjects. The concentratioii
of Pro-Hyp in the serum of patients was much higher
than in either their mother or contröls.
These results suggest that the mother's halved activities
can hydrolyse all the iminodipeptides containing a C:'
terminal proline, which are produced by the metabolisrn
of collagen, so that X-Pro cannot be detected in her ur-
ine. However, low prolidase activities towards X-Hyp in
the mother and normal yolunteers were not sufficient
for the hydrolysis of all the endogenous iminodipeptides
containing a C-terminäl hydroxyprolin.e, so that small
arnounts of unhydrolysed Gly-Hyp and Pro-Hyp are
found in their urines.
This report indicates that LC-APCI-MS (selected ion
monitoring mode) is very usefiil, |br the detection and
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quantification of iminodipeptides in serum, even in very
small amounts, and for studying the relationships be-
tween clinical Symptoms and Collagen metabolism in
patients with prolidase deficiency.
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Fig. 7 Selected ion monitoring normalized chromatograms of Gly-Hyp (189) and Pro-Hyp (229) in
the serum samples from a patient with prolidase deficiency, and in a control.
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